查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602397

急性心室引流市场：依病患类型、应用分类 - 2025-2030 年全球预测

Acute External Ventricular Drain Market by Patient Type (Adult, Pediatric), Application (Intracerebral Hemorrhage, Non-Traumatic Hydrocephalus Conditions, Subarachnoid Hemorrhage) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，急性心室引流市场价值为2.4346亿美元，预计到2024年将达到2.6664亿美元，复合年增长率为9.95%，到2030年将达到4.7319亿美元，预计将达到1000万美元。

急性脑室引流 (EVD) 系统是重要的设备，旨在将脑脊髓液 (CSF) 从脑室转移并在创伤性脑损伤和水脑症。在需要快速介入以防止颅内压增高导致的神经元损伤的急性临床环境中，出现了对 EVD 的需求。 EVD 的主要应用是神经外科、加护病房和急诊医学，最终用户包括医院和神经专科中心。 EVD 市场的成长在很大程度上受到神经系统疾病盛行率上升、神经外科技术进步以及新兴国家医疗保健基础设施发展的影响。此外，日益增长的老年人口更容易患神经系统疾病，进一步推动了需求。该市场的主要消费者正在探索医疗预算不断增加的开拓领域的潜在商机，并利用智慧监控系统整合等技术进步来增强护理。然而，由于安装和维护成本高昂、潜在的感染风险以及缺乏有效处理这些系统的熟练专业人员，该市场面临着限制。创新可以集中于开发具有增强安全性和监控能力的经济高效且侵入性较小的 EVD 系统。也可以考虑研究降低感染风险并延长设备寿命的材料技术。也就是说，市场相关人员应强调培训计划，以应对严格的监管合规挑战并提高 EVD 系统管理技能。 EVD 市场的高度专业化性质要求医疗设备製造商和医疗保健提供者不断合作、促进创新并使服务适应不断变化的临床需求。总之，策略重点是降低成本、技术整合和扩展到新兴市场，可以显着提高市场渗透率和有效性。

主要市场统计
基准年[2023] 2.4346亿美元
预测年份 [2024] 2.6664亿美元
预测年份 [2030] 47319万美元
复合年增长率（%） 9.95%

市场动态：快速发展的急性心室引流市场的关键市场洞察

供需的动态交互作用正在改变急性心室引流市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球非创伤性水脑症的盛行率
    • 监测和调整患者神经状态的需要
    • 患者对微创医疗的倾向
  • 市场限制因素
    • 治疗持续时间和时间的不确定性
  • 市场机会
    • EVD 植入中越来越多地使用即时超音波导航
    • 全球医疗旅游的成长
  • 市场挑战
    • 与急性心室引流相关的风险

波特五力：驾驭急性心室引流市场的策略工具

波特的五力框架是了解急性心室引流市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解急性心室引流市场的外部影响

外部宏观环境因素在塑造急性心室引流市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解急性心室引流市场的竞争状况

对急性心室引流市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵急性心室引流市场供应商的绩效评估

FPNV定位矩阵是评估急性心室引流市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘急性心室引流市场的成功之路

对于希望加强在全球市场的影响力的公司来说，对急性心室引流市场进行策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 非外伤性水脑症的全球盛行率
      • 监测和管理患者神经状况的需要
      • 患者倾向微创医疗程序
    • 抑制因素
      • 治疗时间和持续时间未知
    • 机会
      • EVD 植入中更多地使用即时超音波导航
      • 世界各地的医疗旅游活动增加
    • 任务
      • 与急性心室引流相关的风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按患者类型分類的急性心室引流市场

  • 成人用
  • 小儿科

第七章 急性心室引流市场：依应用分类

  • 脑出血
  • 非外伤性水脑症
  • 蜘蛛网膜下腔出血
  • 脑外伤

第八章北美和南美急性心室引流市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区急性心室引流市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲的急性心室引流市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • B. Braun Medical Inc.
  • Bicakcilar Medical Devices Industry and Trade Inc.
  • Brain Navi Biotechnology Co., Ltd.
  • Cadila Pharmaceuticals Limited
  • Cook Group Incorporated
  • Dispomedica GmbH
  • Fuji Systems Co. Ltd.
  • G. Surgiwear Ltd.
  • Geistlich Pharma Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic Plc
  • Merit Medical Systems
  • Moller Medical Gmbh
  • Natus Medical Incorporated
  • Neuromedex GmbH
  • Nipro Corporation
  • Pfizer Inc.
  • Raumedic AG
  • Salvavidas Pharmaceutical Pvt. Ltd
  • Silmag SA
  • Sophysa SA
  • Spiegelberg Gmbh & Co. Kg
  • Wellong Instruments Co., Ltd.
  • Yushin Medical Co., Ltd.
Product Code: MRR-957C47F8FEC9

The Acute External Ventricular Drain Market was valued at USD 243.46 million in 2023, expected to reach USD 266.64 million in 2024, and is projected to grow at a CAGR of 9.95%, to USD 473.19 million by 2030.

Acute External Ventricular Drain (EVD) systems are critical devices designed for managing intracranial pressure by diverting cerebrospinal fluid (CSF) from the brain's ventricles in conditions like traumatic brain injury or hydrocephalus. The necessity of EVDs arises in acute clinical settings where rapid intervention is needed to prevent neuronal damage from increased intracranial pressure. These devices find primary applications in neurosurgery, intensive care units, and emergency medicine, serving end users such as hospitals and specialized neurological centers. The market growth for EVDs is significantly influenced by rising incidences of neurological disorders, advancements in neurosurgical procedures, and the increasing availability of healthcare infrastructure in emerging economies. Additionally, the rise in the geriatric population susceptible to neurological ailments further propels demand. Key consumers in the market can explore potential opportunities in untapped regions with growing healthcare budgets and leverage technological advancements like integrating smart monitoring systems for enhanced care. However, the market faces limitations in terms of high costs associated with installation and maintenance, potential risks of infection, and a shortage of skilled professionals to handle these systems effectively. Innovation could focus on developing cost-effective, lesser invasive EVD systems with enhanced safety and monitoring capabilities. The research could also explore material technologies that reduce infection risks and extend device longevity. Nonetheless, market players should address the challenges of stringent regulatory compliances and emphasize training programs to enhance skills in managing EVD systems. The nature of the EVD market is highly specialized, requiring continuous collaborations between medical device manufacturers and healthcare providers to foster innovations and tailor services to meet evolving clinical demands. In sum, a strategic focus on cost reduction, technological integration, and expanding into developing regions could significantly enhance market reach and effectiveness.

KEY MARKET STATISTICS
Base Year [2023] USD 243.46 million
Estimated Year [2024] USD 266.64 million
Forecast Year [2030] USD 473.19 million
CAGR (%) 9.95%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acute External Ventricular Drain Market

The Acute External Ventricular Drain Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of non-traumatic hydrocephalus globally
    • Need for monitoring and regulating the neurologic status of patients
    • Inclination of patients toward minimally invasive medical procedures
  • Market Restraints
    • Uncertain time and duration of treatment
  • Market Opportunities
    • Rising use of real-time ultrasound navigation for EVD implantation
    • Increasing medical tourism activities worldwide
  • Market Challenges
    • Risks associated with acute external ventricular drain

Porter's Five Forces: A Strategic Tool for Navigating the Acute External Ventricular Drain Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acute External Ventricular Drain Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acute External Ventricular Drain Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acute External Ventricular Drain Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acute External Ventricular Drain Market

A detailed market share analysis in the Acute External Ventricular Drain Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acute External Ventricular Drain Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acute External Ventricular Drain Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acute External Ventricular Drain Market

A strategic analysis of the Acute External Ventricular Drain Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acute External Ventricular Drain Market, highlighting leading vendors and their innovative profiles. These include B. Braun Medical Inc., Bicakcilar Medical Devices Industry and Trade Inc., Brain Navi Biotechnology Co., Ltd., Cadila Pharmaceuticals Limited, Cook Group Incorporated, Dispomedica GmbH, Fuji Systems Co. Ltd., G. Surgiwear Ltd., Geistlich Pharma Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Merit Medical Systems, Moller Medical Gmbh, Natus Medical Incorporated, Neuromedex GmbH, Nipro Corporation, Pfizer Inc., Raumedic AG, Salvavidas Pharmaceutical Pvt. Ltd, Silmag S.A., Sophysa SA, Spiegelberg Gmbh & Co. Kg, Wellong Instruments Co., Ltd., and Yushin Medical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Acute External Ventricular Drain Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Patient Type, market is studied across Adult and Pediatric.
  • Based on Application, market is studied across Intracerebral Hemorrhage, Non-Traumatic Hydrocephalus Conditions, Subarachnoid Hemorrhage, and Traumatic Brain Injury.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of non-traumatic hydrocephalus globally
      • 5.1.1.2. Need for monitoring and regulating the neurologic status of patients
      • 5.1.1.3. Inclination of patients toward minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertain time and duration of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising use of real-time ultrasound navigation for EVD implantation
      • 5.1.3.2. Increasing medical tourism activities worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with acute external ventricular drain
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acute External Ventricular Drain Market, by Patient Type

  • 6.1. Introduction
  • 6.2. Adult
  • 6.3. Pediatric

7. Acute External Ventricular Drain Market, by Application

  • 7.1. Introduction
  • 7.2. Intracerebral Hemorrhage
  • 7.3. Non-Traumatic Hydrocephalus Conditions
  • 7.4. Subarachnoid Hemorrhage
  • 7.5. Traumatic Brain Injury

8. Americas Acute External Ventricular Drain Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Acute External Ventricular Drain Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Acute External Ventricular Drain Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Medical Inc.
  • 2. Bicakcilar Medical Devices Industry and Trade Inc.
  • 3. Brain Navi Biotechnology Co., Ltd.
  • 4. Cadila Pharmaceuticals Limited
  • 5. Cook Group Incorporated
  • 6. Dispomedica GmbH
  • 7. Fuji Systems Co. Ltd.
  • 8. G. Surgiwear Ltd.
  • 9. Geistlich Pharma Inc.
  • 10. Integra LifeSciences Corporation
  • 11. Johnson & Johnson Services, Inc.
  • 12. Medtronic Plc
  • 13. Merit Medical Systems
  • 14. Moller Medical Gmbh
  • 15. Natus Medical Incorporated
  • 16. Neuromedex GmbH
  • 17. Nipro Corporation
  • 18. Pfizer Inc.
  • 19. Raumedic AG
  • 20. Salvavidas Pharmaceutical Pvt. Ltd
  • 21. Silmag S.A.
  • 22. Sophysa SA
  • 23. Spiegelberg Gmbh & Co. Kg
  • 24. Wellong Instruments Co., Ltd.
  • 25. Yushin Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET RESEARCH PROCESS
  • FIGURE 2. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS
  • TABLE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACEREBRAL HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY NON-TRAUMATIC HYDROCEPHALUS CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023